However, after a certain time, pancreatic beta cells fail to compensate for this abnormality, leading to clinical hyperglycemia, with the skeletal muscle accounting for the most insulin-stimulated glucose disposal; consequently, it is the predominant insulin resistance site in T2D [10,11]. This evidence concerns the gene INS and type 2 diabetes mellitus.